NEWS

MEA’s Priya Desai, MD, MBA Wins Award

Dr. Desai was recently named one of the “10 Best Corrective Eye Surgeons" in New Jerseyfor 201... | read full article

A Friendly Reminder on Glaucoma

Glaucoma is the leading cause of irreversible blindness worldwide. It is also a silent disease which... | read full article

Could You Have Computer Vision Syndrome?

If you are reading this blog, you likely spend several hours a day looking at digital screens: smart... | read full article

read more news stories

Blog

MEA’s Priya Desai, MD, MBA Wins Award

Posted on: Friday, June 16, 2017

 Dr. Desai was recently named one of the “10 Best Corrective Eye Surgeons" in New Jersey for 2017 by the American Institute of Medical Professionals.

The American Institute of Medical Professionals was founded on a big and innovative idea- physicians should be recognized for excellence in their field and that potential patients can benefit from this knowledge. American Institute is an impartial third-party rating recognizing excellence of practitioners in the field. They compile an exclusive list of the “10 Best” physicians for each state. This is a prestigious honor as each awardee:

·         Be formally nominated by the Institute, patients, and/or a fellow physician

·         Have attained the highest degree of professional achievement in his or her field; and

·         Have done so with an impeccable Patient Satisfaction rating.

Many practitioners can achieve high degrees of success but this is often times at the expense or satisfaction of the most important person- the patient. American Institute of Medical Professionals looks for physicians that have achieved unparalleled success but most importantly have done so for the benefit of their patients. Very few practitioners can do so and their organization recognizes this significant achievement.

MEA is honored to have one of its physicians receive this award and continuing our mission to provide exceptional care to our patients at every encounter.

Matossian Eye Associates is a center of excellence for comprehensive eye exams, cataracts, glaucoma, dry eye, retina, cornea, contact lenses, and clinical trials, featuring outstanding services offered by nationally recognized doctors.  For a consultation, please call our toll free number at 1-800-708-8800 or visit us at www.matossianeye.com.

A Friendly Reminder on Glaucoma

Posted on: Wednesday, June 14, 2017

Glaucoma is the leading cause of irreversible blindness worldwide. It is also a silent disease which makes it even more dangerous. The patient doesn't have any pain, no vision changes and no change in the appearance of the eye, until the glaucoma becomes severe.  


As a result, a yearly eye exam is very important for glaucoma screening and diagnosing the disease before it causes any major damage, especially those with a family history of glaucoma. We now offer many options for glaucoma treatment including:

·         eye drops

·         in office laser procedures

·         micro invasive glaucoma surgery (MIGS)

The earlier the diagnosis the less invasive the treatment. If you missed your yearly eye exam, you can schedule an appointment today by calling 1-800-708-8800.

Matossian Eye Associates is a Center Of Excellence for medical, surgical, and laser treatment of Glaucoma, featuring outstanding services offered by nationally recognized doctors. For a consultation, please call our toll-free number at 1-800-708-8800 or visit us at www.matossianeye.com.

Priya V. Desai, MD, MBA

Medical & Surgical Glaucoma

 

Comprehensive Ophthalmology & Cataracts

Could You Have Computer Vision Syndrome?

Posted on: Tuesday, June 13, 2017

If you are reading this blog, you likely spend several hours a day looking at digital screens: smart phones, tablets, computers, and TVs.  In fact, it is almost impossible not to spend a significant amount of time on these various screens in your daily life. Since “screen time” is increasing, we have also noticed an increase in dry eye syndrome. This relationship has given rise to a newer form of dry eye that is sometimes called Computer Vision Syndrome (CVS). 

CVS, also referred to as Digital Eye Strain(DES), is a group of eye and vision-related problems that result from prolonged computer, tablet, e-reader and cell phone use. Many individuals experience eye discomfort and vision problems when viewing digital screens for extended periods. The level of discomfort appears to increase with the amount of digital screen use.

The most common symptoms associated with CVS or DES are:

  • eyestrain
  • headaches
  • blurred vision
  • dry eyes
  • neck and shoulder pain

These symptoms may be caused by:

  • poor lighting
  • glare on a digital screen
  • improper viewing distances
  • poor seating posture
  • uncorrected vision problems
  • prolonged periods without blinking
  • a combination of these factors

The best way to help alleviate bothersome symptoms of CVS and help improve your vision with long screen time is to have a good regiment of warm compresses, eyelid scrubs, oral Omega 3s, and artificial tear drops.  Taking a 20 second break from your screen every 20 minutes by looking at something 20 feet away (the 20-20-20 rule) can really help these symptoms as well.

Matossian Eye Associates is a Certified Center of Excellence for Dry Eyes, featuring outstanding services offered by nationally recognized doctors. For a consultation on the root causes of and the best treatments for your dry eyes, please call our toll-free number at 1-800-708-8800 or visit us at www.matossianeye.com.

Priya V. Desai, MD, MBA

Medical & Surgical Glaucoma

Comprehensive Ophthalmology & Cataracts

 

Matossian Eye Associates

Save on Lipiflow Through June

Posted on: Thursday, June 08, 2017

Tags: dry eye, mgd, lipiflow

Many who suffer the symptoms of Dry Eye may have Meibomian Gland Dysfunction (MGD). LipiView® (dynamic Meibomian imaging) is used to determine whether or not you suffer from MGD.  If you have Meibomian Gland drop out, how is the condition treated? 

 

LipiFlow® (vectored thermal pulsation MGD treatment) is designed to treat the root cause of evaporative dry eye disease caused by MGD, by unplugging the blocked meibomian glands.  It is a very safe option with over 150,000 treatments performed in the US to date.  Opening and clearing these blocked glands will allow them to resume their natural production of lipids (oils) needed for a healthy tear film. A disposable activator is placed on each eyelid.  These eyepieces use a patented, precisely controlled heat that is applied to the inner eyelid with pulsed pressure to unblock the glands.  This system also encourages the glands to resume their natural production of the lipids needed for healthy tears.  Its single-use design and built-in sensors ensure a safe, sterile treatment.  The spa-like process is pain free, very soothing, and lasts approximately 15 minutes.   This treatment is usually recommended once a year.  LipiFlow is the only FDA-cleared thermal pulsation treatment for MGD

 

Now until the end of June 2017, the manufacturer of Lipiflow is offering a $50 rebate for patients who receive a treatment (restrictions apply). If you would like to take advantage of this rebate, please follow the instructions found on the manufacture’s website, found here, to redeem.

 

$50 Rebate for LipiFlow® Treatment Marketing Survey

 

Matossian Eye Associates is a Certified Center of Excellence for Dry Eyes, featuring outstanding services offered by nationally recognized doctors. For a consultation on the root causes of and the best treatments for your dry eyes, please call our toll-free number at 1-800-708-8800 or visit us at www.matossianeye.com.

Sustained Release Glaucoma Medication

Posted on: Wednesday, June 07, 2017

Traditional eye drops are the go-to medication for many glaucoma patients. When it comes to eye drops however, there is always room for improvement. Dosing regiments can be difficult to manage or remember and much of the medication can get blinked away before reaching the eye. Because of these downfalls, researches are working on sustained-release medications, to even release a drug over time.

Having a sustained-released medication can lengthen the intervals of taking medications. What was once needed to be taken daily, could potentially be applied weekly, monthly, or longer. This can increase medication compliance and drug delivery efficiency.

There are many sustained-release options in the pipeline currently. For example, the University of Southern California's Roski Eye Institute developed a micropump that is implanted directly into the eye. It is then controlled by a wireless device and replenished by injecting medication through a port.

Meanwhile, researchers at Boston Children's Hospital and Harvard Medical School have been working on a contact lens that not only corrects eyesight but also contains a drug-polymer film along the edge that slowly dispenses glaucoma medication.

Perhaps the most ambitious take on sustained-release technology is Allergan's biodegradable sustained-release bimatoprost implant. This implant uses a prefilled, single-use applicator system. Once it is in place in the eye, it slowly dispenses the drug and then biodegrades, making device removal unnecessary.

All these new approaches to glaucoma medication are slated to reach the doctor's office in the coming years. This means that soon, patients may no longer need to deal with the hassle that comes with current eye drop medication regimens.

Matossian Eye Associates is a Center Of Excellence for medical, surgical, and laser treatment of Glaucoma, featuring outstanding services offered by nationally recognized doctors. For a consultation, please call our toll-free number at 1-800-708-8800 or visit us at www.matossianeye.com.

Source: https://www.sciencedaily.com/releases/2017/05/170531092918.htm